Maria Bedoya-Toro Munera
Conseiller Juridique Général chez DERMATA THERAPEUTICS, INC.
Fortune : 1 833 $ au 31/05/2024
Profil
Maria Bedoya-Toro Munera is currently working as the Senior VP-Regulatory Affairs & Quality Assurance at Dermata Therapeutics, Inc. She previously held positions as the Director-Quality Assurance & Regulatory Compliance at Amylin Pharmaceuticals, Inc. from 1996 to 1998, the Senior Director-Global Regulatory Affairs at Ligand Pharmaceuticals, Inc. from 2003 to 2006, the Senior Director-Regulatory Affairs at Eisai Medical Research, Inc. from 2006 to 2007, the Director-Global Regulatory Affairs at Baxter Hyland Immuno from 2000 to 2003, the Director-Regulatory Affairs & Quality at BASF Bioresearch Corp.
from 1998 to 2000, the Senior VP-Regulatory Affairs & Quality Assurance at Santarus, Inc. from 2011 to 2014, and the Senior VP-Regulatory Affairs & Quality Assurance at Receptos LLC from 2014 to 2015.
She holds an MBA from The University of Chicago, a doctorate from The Ohio University, and undergraduate and graduate degrees from Western Michigan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/01/2024 | 478 ( 0,11% ) | 1 833 $ | 31/05/2024 |
Postes actifs de Maria Bedoya-Toro Munera
| Sociétés | Poste | Début |
|---|---|---|
| DERMATA THERAPEUTICS, INC. | Conseiller Juridique Général | 01/01/2016 |
Anciens postes connus de Maria Bedoya-Toro Munera
| Sociétés | Poste | Fin |
|---|---|---|
| RECEPTOS INC | Conseiller Juridique Général | 01/01/2015 |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Conseiller Juridique Général | 02/01/2014 |
| Eisai Medical Research, Inc. | Conseiller Juridique Général | 01/05/2007 |
| LIGAND PHARMACEUTICALS INCORPORATED | Conseiller Juridique Général | 01/01/2006 |
| Baxter Hyland Immuno | Conseiller Juridique Général | 01/01/2003 |
Formation de Maria Bedoya-Toro Munera
| The University of Chicago | Masters Business Admin |
| The Ohio University | Doctorate Degree |
| Western Michigan University | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| DERMATA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Santarus, Inc.
Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
| Eisai Medical Research, Inc. | |
| Baxter Hyland Immuno | |
| BASF Bioresearch Corp. |
